- Report
- January 2024
- 200 Pages
Global
From €4846EUR$5,000USD£4,150GBP
- Report
- September 2018
- 30 Pages
China
From €2132EUR$2,200USD£1,826GBP
- Report
- February 2024
- 118 Pages
Global
From €3500EUR$3,869USD£3,103GBP
- Report
- April 2024
- 50 Pages
Global
From €2568EUR$2,650USD£2,200GBP
- Report
- November 2023
- 215 Pages
China
From €3876EUR$4,000USD£3,320GBP
- Report
- November 2023
- 109 Pages
China
From €1744EUR$1,800USD£1,494GBP
Irbesartan is a medication used to treat high blood pressure and heart failure. It belongs to a class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow and increases blood pressure. Irbesartan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy, a condition in which the heart's left ventricle is enlarged.
Irbesartan is available as a generic drug and is marketed under several brand names, including Avapro, Karvea, and Aprovel. It is available in tablet form and is usually taken once or twice daily.
In the Irbesartan market, some of the companies include Sanofi, Bristol-Myers Squibb, Daiichi Sankyo, and Teva Pharmaceuticals. Show Less Read more